News

Vaccine development is an arduous process, taking about 10-15 years on average to accomplish. But with the imminent worries surrounding the COVID-19 pandemic putting unprecedented pressure on our healthcare systems and economies, unprecedented measures needed to be put in place.

While you’ve likely answered many of these before, it never hurts to brush up on solid answers and think of new or recent anecdotes to illustrate your point.

Children, who have not been widely tested in clinical trials for the vaccine, are typically less severely affected and are much further down the priority list for receiving the vaccines. But the vaccine has not been tested at all in younger children.

While promising, the study showed no difference between this combination regimen and physician’s choice of topotecan or cyclophosphamide/doxorubicin/vincristine (CAV) in terms of overall survival (OS).

Upping the numbers two times, Silverback now readies a 10 million share offering.